Drug Screening Market Analysis, Business Intelligence With Roche, LabCorp, Abbott, Alere Inc., bioMérieux, Siemens Healthineers, Thermo Fisher Scientific, Quest Diagnostics, Express Diagnostics International, Inc. , Bio-Rad Laboratories, Drägerwerk AG

The drug screening report provides with the complete knowledge and information of rapidly changing market landscape, what is already there in the market, future trends or market expectations, the competitive environment, and competitor strategies that aids in planning your own strategies with which you can outshine the competitors. The precise and state-of-the-art information provided via this report helps businesses get aware about the types of drug screening consumers, consumer’s demands and preferences, their point of view about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in the market.

The forecast, analysis, evaluations and estimations carried out in this drug screening report are all based upon the well established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. The market type, organization size, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa are kept at the centre while building this global drug screening market report. Thus, the wide-ranging market information of the drug screening report will surely grow business and improve return on investment (ROI).

Drug screening market is expected to rise gradually to an estimated value of USD 19.03 billion by 2026, registering a CAGR of 12.9% in the forecast period of 2019-2026 with the annual sales of USD 7.21 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of people.

Get Free Sample PDF Copy of This Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post-accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance, ketamine, phenethylamines, and piperazine are rising in the drug market.

According to World Health Organization, there were an estimated 3.3 million people died due to harmful effects of only alcohol, almost more than half of these deaths could have been avoided with the development, organization, monitoring and evaluation of treatment and other services. This significant number is expected to act as a driver to the market growth.

Few of the major competitors currently working in the drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France), Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S), Shimadzu Medical Pvt. Ltd. (Japan) and few among others.

Market Drivers

· Increasing government funding and initiatives for drug testing.

· Rising awareness on drug screening policy

· Growing alcohol and drug abuse in developing countries.


Market Restraints

· In some countries drug testing is considered as a violation of privacy rights.

· Accuracy issues with the breathalyzers.


Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-screening-market

Key Developments in the Market:

· On 6th July, 2017, Endo Pharmaceuticals agreed to remove Opana ER (oxymorphone), its abuse-deterrent extended-release formulation of from the US market a month later the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.

· On 19th July 2017, Alere Inc., a global leader in rapid diagnostics, announced the availability of Alere iCup , its point-of-care Rx Drug Screen, a rapid urine test that detects five of the most commonly misused and abused prescription drugs which are benzodiazepines, buprenorphine, methadone, opiates and oxycodone. This innovative approach will help the company to generate more revenue.


Segmentation: Global Drug Screening Market

By Product and services

· Equipment

• Immunoassay Analyzers

• Chromatography Instruments

• Breath Analyzers

o Fuel Cell Breathalyzers

o Semiconductor Breathalyzers

o Other Devices

· Rapid Testing Devices

1. Urine Testing Devices

· Urine Testing Cups

· Dip Cards

· Cassettes

2. Oral Fluid Testing Devices

• Consumables

o Assay Kits

o Sample Collection Cups

o Calibrators and Controls

o Others

• Laboratory Services

By Sample Type

· Urine

· Breath

· Saliva, Hair

· Blood

· Skin

· Sweat

By End- users

· Workplace and Schools

· Drug Testing Laboratories

· Criminal Justice System & Law Enforcement Agencies

· Hospitals

· Drug Treatment Centers

· Pain Management Centers

· Personal Users

By Geography

· North America

US.
Canada
Mexico

· South America

Brazil
Argentina
Rest of South America

· Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe

· Asia-Pacific

Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific

· Middle East & Africa

South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa


Global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug screening market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-screening-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.